Michael Malia, PhD, is currently the Director of Scientific Communications at Dexcom and the Principal at M. Malia Communications, LLC, where they focus on scientific communications and medical affairs consulting. They served as the Director of Scientific Communications at AVEO Oncology from 2022 to 2024 and held the role of Scientific Communications Director at Y-mAbs Therapeutics, Inc. from 2020 to 2022. Previously, Michael gained extensive experience in various roles, including Senior Director of Medical Affairs at CTI BioPharma and Associate Director of Global Scientific Communications at Celgene. They earned a BA in Biology from the University of Delaware and a PhD in Biology from The George Washington University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices